This report shares the results of a pilot introduction of oxytocin in the Uniject® device for use with active management of the third stage of labor that was conducted at the institutional level in Guatemala in 2009. Results include details on the feasibility of introducing oxytocin in Uniject in this context as well as the acceptability of this technology among health care providers and facility managers. The cost analysis can be found here.

Corporate author(s): PATH

Publication date: March 2010

Available materials



Pilot Introduction of Oxytocin in Uniject® During Active Management of the Third Stage of Labor (AMTSL) at the Institutional Level in Guatemala [Spanish]

491 KB PDF

Also known as: Piloto de Introducción de Oxitocina en Dispositivo Uniject™ Durante el Manejo Activo de la Tercera Etapa del Parto (MATEP) a Nivel Institucional en Guatemala

Hard copies are not available.

Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.

Related regions: Latin America

See also:

For more information…

Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA